{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:52:52Z","timestamp":1773417172614,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69193-7","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:52:29Z","timestamp":1770353549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus"],"prefix":"10.1038","volume":"17","author":[{"given":"Chan Woo","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-5934","authenticated-orcid":false,"given":"Mohamed El-Agamy","family":"Farh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soohyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Un Ho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5001-5875","authenticated-orcid":false,"given":"Jung Ho","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeonuk","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-3467","authenticated-orcid":false,"given":"Jae Woong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Soo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-3012","authenticated-orcid":false,"given":"Jong-Pil","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Je","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-5567","authenticated-orcid":false,"given":"Sungsoon","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4693-738X","authenticated-orcid":false,"given":"Hyongbum Henry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-5415","authenticated-orcid":false,"given":"Byung Kook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insuk","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-9630","authenticated-orcid":false,"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"69193_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00000658-198709000-00009","volume":"206","author":"WJ Pories","year":"1987","unstructured":"Pories, W. J., Flickinger, C. aroJ. F., Meelheim, E. G. & Swanson, H. D. MS. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann. Surg. 206, 316\u2013323 (1987).","journal-title":"Ann. Surg."},{"key":"69193_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/00000658-199206000-00010","volume":"215","author":"WJ Pories","year":"1992","unstructured":"Pories, W. J. et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann. Surg. 215, 633\u2013642 (1992).","journal-title":"Ann. Surg."},{"key":"69193_CR3","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","volume":"370","author":"PR Schauer","year":"2014","unstructured":"Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N. Engl. J. Med. 370, 2002\u20132013 (2014).","journal-title":"N. Engl. J. Med."},{"key":"69193_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00000658-199509000-00011","volume":"222","author":"WJ Pories","year":"1995","unstructured":"Pories, W. J. et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg. 222, 339\u2013350 (1995).","journal-title":"Ann. Surg."},{"key":"69193_CR5","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1136\/gutjnl-2020-321402","volume":"70","author":"IG Kwon","year":"2021","unstructured":"Kwon, I. G. et al. Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 70, 1847\u20131856 (2021).","journal-title":"Gut"},{"key":"69193_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/db16-1000","volume":"66","author":"CR Ku","year":"2017","unstructured":"Ku, C. R. et al. Intestinal glycolysis visualized by FDG PET\/CT correlates with glucose decrement after gastrectomy. Diabetes 66, 385\u2013391 (2017).","journal-title":"Diabetes"},{"key":"69193_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937394","volume":"13","author":"JH Oh","year":"2022","unstructured":"Oh, J. H. et al. Altered glucose metabolism and glucose transporters in systemic organs after bariatric surgery. Front. Endocrinol. 13, 937394 (2022).","journal-title":"Front. Endocrinol."},{"key":"69193_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1053\/j.gastro.2015.10.009","volume":"150","author":"JB Cavin","year":"2016","unstructured":"Cavin, J. B. et al. Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology 150, 454\u2013464.e459 (2016).","journal-title":"Gastroenterology"},{"key":"69193_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/SLA.0b013e3182890311","volume":"258","author":"CF Jurowich","year":"2013","unstructured":"Jurowich, C. F. et al. Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes. Ann. Surg. 258, 89\u201397 (2013).","journal-title":"Ann. Surg."},{"key":"69193_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmet.2008.08.008","volume":"8","author":"S Troy","year":"2008","unstructured":"Troy, S. et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 8, 201\u2013211 (2008).","journal-title":"Cell Metab."},{"key":"69193_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1126\/science.1235103","volume":"341","author":"N Saeidi","year":"2013","unstructured":"Saeidi, N. et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 341, 406\u2013410 (2013).","journal-title":"Science"},{"key":"69193_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins, S., Mestres, J. & Testa, B. In silico pharmacology for drug discovery: applications to targets and beyond. Br. J. Pharm. 152, 21\u201337 (2007).","journal-title":"Br. J. Pharm."},{"key":"69193_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4155\/fmc.13.207","volume":"6","author":"PS Kharkar","year":"2014","unstructured":"Kharkar, P. S., Warrier, S. & Gaud, R. S. Reverse docking: a powerful tool for drug repositioning and drug rescue. Future Med. Chem. 6, 333\u2013342 (2014).","journal-title":"Future Med. Chem."},{"key":"69193_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"69193_CR15","first-page":"1437","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000. Profiles Cell 171, 1437\u20131452.e1417 (2017).","journal-title":"Profiles Cell"},{"key":"69193_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"69193_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/npjsba.2016.15","volume":"2","author":"Q Duan","year":"2016","unstructured":"Duan, Q. et al. L1000CDS(2): LINCS L1000 characteristic direction signatures search engine. NPJ Syst. Biol. Appl. 2, 16015 (2016).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"69193_CR18","first-page":"506","volume":"19","author":"A Musa","year":"2018","unstructured":"Musa, A. et al. A review of connectivity map and computational approaches in pharmacogenomics. Brief. Bioinform. 19, 506\u2013523 (2018).","journal-title":"Brief. Bioinform."},{"key":"69193_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1440-0960.2008.00497.x","volume":"50","author":"G Siller","year":"2009","unstructured":"Siller, G., Gebauer, K., Welburn, P., Katsamas, J. & Ogbourne, S. M. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Australas. J. Dermatol. 50, 16\u201322 (2009).","journal-title":"Australas. J. Dermatol."},{"key":"69193_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/toxins2010174","volume":"2","author":"E Ersvaer","year":"2010","unstructured":"Ersvaer, E. et al. The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity. Toxins 2, 174\u2013194 (2010).","journal-title":"Toxins"},{"key":"69193_CR21","first-page":"2507","volume":"53","author":"Z Szallasi","year":"1993","unstructured":"Szallasi, Z., Krsmanovic, L. & Blumberg, P. M. Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin. Cancer Res. 53, 2507\u20132512 (1993).","journal-title":"Cancer Res."},{"key":"69193_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2007-969623","volume":"50","author":"S Zayed","year":"1984","unstructured":"Zayed, S., Sorg, B. & Hecker, E. Structure activity relations of polyfunctional diterpenes of the tigliane type, VI. Irritant and tumor promoting activities of semisynthetic mono and diesters of 12-deoxyphorbol. Planta Med. 50, 65\u201369 (1984).","journal-title":"Planta Med."},{"key":"69193_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrc2110","volume":"7","author":"EM Griner","year":"2007","unstructured":"Griner, E. M. & Kazanietz, M. G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7, 281\u2013294 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"69193_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tips.2017.02.002","volume":"38","author":"AC Newton","year":"2017","unstructured":"Newton, A. C. & Brognard, J. Reversing the paradigm: protein kinase C as a tumor suppressor. Trends Pharm. Sci. 38, 438\u2013447 (2017).","journal-title":"Trends Pharm. Sci."},{"key":"69193_CR25","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1093\/nar\/16.11.5199","volume":"16","author":"Y Ono","year":"1988","unstructured":"Ono, Y. et al. Nucleotide-sequences of cDNAs for alpha-subspecies and gamma-subspecies of rat-brain protein kinase-C. Nucleic Acids Res. 16, 5199\u20135200 (1988).","journal-title":"Nucleic Acids Res."},{"key":"69193_CR26","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1016\/S0021-9258(18)68732-0","volume":"263","author":"Y Ono","year":"1988","unstructured":"Ono, Y. et al. The structure, expression, and properties of additional members of the protein kinase-C family. J. Biol. Chem. 263, 6927\u20136932 (1988).","journal-title":"J. Biol. Chem."},{"key":"69193_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/en.2002-221017","volume":"144","author":"Y Kanoh","year":"2003","unstructured":"Kanoh, Y. et al. Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes. Endocrinology 144, 947\u2013954 (2003).","journal-title":"Endocrinology"},{"key":"69193_CR28","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1172\/JCI31408","volume":"117","author":"RV Farese","year":"2007","unstructured":"Farese, R. V. et al. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J. Clin. Invest. 117, 2289\u20132301 (2007).","journal-title":"J. Clin. Invest."},{"key":"69193_CR29","doi-asserted-by":"publisher","first-page":"e12565","DOI":"10.14814\/phy2.12565","volume":"3","author":"H Yu","year":"2015","unstructured":"Yu, H. et al. Contraction stimulates muscle glucose uptake independent of atypical PKC. Physiol. Rep. 3, e12565 (2015).","journal-title":"Physiol. Rep."},{"key":"69193_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.devcel.2015.09.016","volume":"35","author":"MJ Bailey","year":"2015","unstructured":"Bailey, M. J. & Prehoda, K. E. Establishment of par-polarized cortical domains via phosphoregulated membrane motifs. Dev. Cell 35, 199\u2013210 (2015).","journal-title":"Dev. Cell"},{"key":"69193_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.celrep.2018.12.079","volume":"26","author":"C Xu","year":"2019","unstructured":"Xu, C. et al. The septate junction protein Tsp2A restricts intestinal stem cell activity via endocytic regulation of aPKC and hippo signaling. Cell Rep. 26, 670\u2013688.e676 (2019).","journal-title":"Cell Rep."},{"key":"69193_CR32","doi-asserted-by":"publisher","first-page":"eaat6662","DOI":"10.1126\/scisignal.aat6662","volume":"12","author":"T Kajimoto","year":"2019","unstructured":"Kajimoto, T. et al. Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter. Sci. Signal 12, eaat6662 (2019).","journal-title":"Sci. Signal"},{"key":"69193_CR33","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.2337\/diabetes.52.8.1926","volume":"52","author":"M Beeson","year":"2003","unstructured":"Beeson, M. et al. Activation of uptake in IEC18 cells treated with DMSO, Pro, or Pro-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52, 1926\u20131934 (2003).","journal-title":"Diabetes"},{"key":"69193_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119839","volume":"239","author":"A Lee","year":"2020","unstructured":"Lee, A. et al. Amino acid-based compound activates atypical PKC and leptin receptor pathways to improve glycemia and anxiety like behavior in diabetic mice. Biomaterials 239, 119839 (2020).","journal-title":"Biomaterials"},{"key":"69193_CR35","first-page":"49","volume":"2","author":"M Beeson","year":"2004","unstructured":"Beeson, M. et al. Defective activation of protein kinase C-z in muscle by insulin and phosphatidylinositol-3,4,5,-(PO(4))(3) in obesity and polycystic ovary syndrome. Metab. Syndr. Relat. Disord. 2, 49\u201356 (2004).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"69193_CR36","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota, M. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3, 96ra77 (2011).","journal-title":"Sci. Transl. Med."},{"key":"69193_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","volume":"13","author":"SD Kunkel","year":"2011","unstructured":"Kunkel, S. D. et al. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 13, 627\u2013638 (2011).","journal-title":"Cell Metab."},{"key":"69193_CR38","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1182\/blood-2007-11-126003","volume":"111","author":"DC Hassane","year":"2008","unstructured":"Hassane, D. C. et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 111, 5654\u20135662 (2008).","journal-title":"Blood"},{"key":"69193_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/febs.12672","volume":"281","author":"L Gao","year":"2014","unstructured":"Gao, L. et al. Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-Parkinson agents. FEBS J. 281, 1110\u20131122 (2014).","journal-title":"FEBS J."},{"key":"69193_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tem.2007.11.005","volume":"19","author":"F Beguinot","year":"2008","unstructured":"Beguinot, F. & Formisano, P. Atypical protein kinase C dysfunction and the metabolic syndrome. Trends Endocrinol. Metab. 19, 39\u201341 (2008).","journal-title":"Trends Endocrinol. Metab."},{"key":"69193_CR41","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2337\/db07-1769","volume":"57","author":"C Schmitz-Peiffer","year":"2008","unstructured":"Schmitz-Peiffer, C. & Biden, T. J. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 57, 1774\u20131783 (2008).","journal-title":"Diabetes"},{"key":"69193_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BJ20040797","volume":"384","author":"RR Bosch","year":"2004","unstructured":"Bosch, R. R. et al. Regulation of GLUT1-mediated glucose uptake by PKClambda-PKCbeta(II) interactions in 3T3-L1 adipocytes. Biochem. J. 384, 349\u2013355 (2004).","journal-title":"Biochem. J."},{"key":"69193_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211933120","volume":"120","author":"N Tobar","year":"2023","unstructured":"Tobar, N. et al. Metformin acts in the gut and induces gut-liver crosstalk. Proc. Natl. Acad. Sci. USA 120, e2211933120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69193_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","volume":"21","author":"FA Duca","year":"2015","unstructured":"Duca, F. A. et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21, 506\u2013511 (2015).","journal-title":"Nat. Med."},{"key":"69193_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"LJ McCreight","year":"2016","unstructured":"McCreight, L. J., Bailey, C. J. & Pearson, E. R. Metformin and the gastrointestinal tract. Diabetologia 59, 426\u2013435 (2016).","journal-title":"Diabetologia"},{"key":"69193_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13340-021-00545-y","volume":"13","author":"H Tsuchida","year":"2022","unstructured":"Tsuchida, H., Morita, Y., Nogami, M. & Ogawa, W. Metformin action in the gut-insight provided by [(18)F]FDG PET imaging. Diabetol. Int. 13, 35\u201340 (2022).","journal-title":"Diabetol. Int."},{"key":"69193_CR47","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc20-0093","volume":"43","author":"Y Morita","year":"2020","unstructured":"Morita, Y. et al. Enhanced release of glucose into the intraluminal space of the intestine associated with metformin treatment as revealed by [(18)F]Fluorodeoxyglucose PET-MRI. Diab. Care 43, 1796\u20131802 (2020).","journal-title":"Diab. Care"},{"key":"69193_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s43856-025-00755-4","volume":"5","author":"K Sakaguchi","year":"2025","unstructured":"Sakaguchi, K. et al. Metformin-regulated glucose flux from the circulation to the intestinal lumen. Commun. Med. 5, 44 (2025).","journal-title":"Commun. Med."},{"key":"69193_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ccell.2020.05.018","volume":"38","author":"Y Kudo","year":"2020","unstructured":"Kudo, Y. et al. PKClambda\/iota loss induces autophagy, oxidative phosphorylation, and NRF2 to promote liver cancer progression. Cancer Cell 38, 247\u2013262.e211 (2020).","journal-title":"Cancer Cell"},{"key":"69193_CR50","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2015.10.041","volume":"163","author":"MT Wang","year":"2015","unstructured":"Wang, M. T. et al. K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling. Cell 163, 1237\u20131251 (2015).","journal-title":"Cell"},{"key":"69193_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1859","volume":"3","author":"G Blandino","year":"2012","unstructured":"Blandino, G. et al. Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. Nat. Commun. 3, 865 (2012).","journal-title":"Nat. Commun."},{"key":"69193_CR52","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1158\/0008-5472.CAN-19-2852","volume":"80","author":"J Xie","year":"2020","unstructured":"Xie, J. et al. GPD1 enhances the anticancer effects of metformin by synergistically increasing total cellular glycerol-3-phosphate. Cancer Res. 80, 2150\u20132162 (2020).","journal-title":"Cancer Res."},{"key":"69193_CR53","doi-asserted-by":"publisher","first-page":"42008","DOI":"10.1074\/jbc.M402124200","volume":"279","author":"SA Williams","year":"2004","unstructured":"Williams, S. A. et al. Prostratin antagonizes HIV latency by activating NF-kappaB. J. Biol. Chem. 279, 42008\u201342017 (2004).","journal-title":"J. Biol. Chem."},{"key":"69193_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD Muller","year":"2019","unstructured":"Muller, T. D. et al. Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30, 72\u2013130 (2019).","journal-title":"Mol. Metab."},{"key":"69193_CR55","doi-asserted-by":"publisher","first-page":"706907","DOI":"10.3389\/fgene.2021.706907","volume":"12","author":"CH Gao","year":"2021","unstructured":"Gao, C. H., Yu, G. & Cai, P. ggVennDiagram: an intuitive, easy-to-use, and highly customizable R package to generate venn diagram. Front. Genet. 12, 706907 (2021).","journal-title":"Front. Genet."},{"key":"69193_CR56","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"69193_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69193-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:02:44Z","timestamp":1773406964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69193-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69193"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69193-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.W.K., J.H.O., E.K.W. and C.R.K. are co-inventors on a pending patent application (PCT\/KR2022\/002035) filed by Yonsei University College of Medicine and Arontier Corporation, covering a composition for glucose regulation containing aPKC activators described in this manuscript. I.S., Z.H, M.E.F. and U.K. are employees of Arontier Corporation. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2417"}}